This suggests that MMSET activation may play a more critical role than FGFR3 in the pathogenesis of MM with t(4;14), contributing to increased proliferation, a change in cellular adhesion, and high tumorigenicity [27]. The gene discussed is NSD2; the disease is Miyoshi myopathy.